Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.99 USD | -1.32% | -5.24% | -12.51% |
14/05 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
10/05 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.51% | 6.2B | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc., Q2 2022 Earnings Call, Aug 09, 2022